CAS 1370256-78-2

Fórmula: C25H27N7O3S2

InChI: InChI=1S/C25H27N7O3S2/c1-17-3-5-18(6-4-17)28-23(33)29-24-30-31-25(37-24)36-22-20-8-7-19(15-21(20)26-16-27-22)35-12-2-9-32-10-13-34-14-11-32/h3-8,15-16H,2,9-14H2,1H3,(H2,28,29,30,33)

Chave InChI: LKXFSTAQMOENSC-UHFFFAOYSA-N

SMILES: CC1=CC=C(C=C1)NC(=O)NC2=NN=C(S2)SC3=NC=NC4=C3C=CC(=C4)OCCCN5CCOCC5

Urea, N-(4-methylphenyl)-N'-[5-[[7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]thio]-1,3,4-thiadiazol-2-yl]-

CAS: 1370256-78-2

Fórmula: C₂₅H₂₇N₇O₃S₂

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 537.6570

Ref: IN-DA0012Q0

SKLB4771

CAS: 1370256-78-2

SKLB4771

Fórmula: C₂₅H₂₇N₇O₃S₂

Pureza: ≥98%

Peso molecular: 537.66

Ref: 54-BUP07087

SKLB4771

CAS: 1370256-78-2

SKLB4771 (FLT3-IN-1) is a novel potent and selective Flt3 inhibitor.

Fórmula: C₂₅H₂₇N₇O₃S₂

Pureza: 98% - 99.74%

Cor e Forma: Solid

Peso molecular: 537.66

Ref: TM-T2051

SKLB4771 (FLT3-IN-1)

CAS: 1370256-78-2

SKLB4771 (FLT3-IN-1) is a selective small molecule inhibitor predominantly known for targeting FLT3, a receptor tyrosine kinase implicated in various hematological malignancies. Originating from a structure-based design and optimization process, this compound functions by competitively inhibiting the ATP-binding site of FLT3, thereby obstructing its autophosphorylation and subsequent downstream signaling cascades.

Fórmula: C₂₅H₂₇N₇O₃S₂

Pureza: Min. 95%

Peso molecular: 537.66 g/mol

Ref: 3D-VEC25678